Skip to main content
Top
Published in: European Radiology 9/2017

01-09-2017 | Cardiac

The prognostic value of right ventricular long axis strain in non-ischaemic dilated cardiomyopathies using standard cardiac magnetic resonance imaging

Authors: Nisha Arenja, Johannes H. Riffel, Manuel Halder, Charly N. Djiokou, Thomas Fritz, Florian Andre, Fabian aus dem Siepen, Thomas Zelniker, Benjamin Meder, Elham Kayvanpour, Grigorios Korosoglou, Hugo A. Katus, Sebastian J. Buss

Published in: European Radiology | Issue 9/2017

Login to get access

Abstract

Objective

To investigate the association of right ventricular long axis strain (RV-LAS), a parameter of longitudinal function, with outcome in patients with non-ischaemic dilated cardiomyopathy (NIDCM).

Methods

In 441 patients with NIDCM, RV-LAS was analysed retrospectively by measuring the length between the epicardial border of the left ventricular apex and the middle of a line connecting the origins of the tricuspidal valve leaflets in end-diastole and end-systole on non-contrast standard cine sequences.

Results

The primary endpoint (cardiac death or heart transplantation) occurred in 41 patients, whereas 95 reached the combined endpoint (including cardiac decompensation and sustained ventricular arrhythmias) during a median follow-up of 4.2 years. Kaplan-Meier survival curves showed a poor outcome in patients with RV-LAS values below −10% (log-rank, p < 0.0001). In a risk stratification model RV-LAS improved prediction of outcome in addition to RV ejection fraction (RVEF) and presence of late gadolinium enhancement. Assessment of RV-LAS offered incremental information compared to clinical symptoms, biomarkers and RVEF. Even in the subgroup with normal RVEF (>45%, n = 213) reduced RV-LAS was still associated with poor outcome.

Conclusion

Assessment of RV-LAS is an independent indicator of outcome in patients with NIDCM and offers incremental information beyond clinical and cardiac MR parameters.

Key points

Impaired right ventricular longitudinal function (RV-LAS) is associated with poorer cardiac outcomes.
Poor outcome is associated with decreased RV-LAS even in patients with RVEF >45%.
Addition of RV-LAS to known risk factors enhances the power prognostic information.
Literature
1.
go back to reference Elliott P, Andersson B, Arbustini E et al (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270–276CrossRefPubMed Elliott P, Andersson B, Arbustini E et al (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270–276CrossRefPubMed
2.
go back to reference Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816CrossRefPubMed Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816CrossRefPubMed
3.
go back to reference Felker GM, Thompson RE, Hare JM et al (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077–1084CrossRefPubMed Felker GM, Thompson RE, Hare JM et al (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077–1084CrossRefPubMed
4.
go back to reference Doesch C, Dierks DM, Haghi D et al (2014) Right ventricular dysfunction, late gadolinium enhancement, and female gender predict poor outcome in patients with dilated cardiomyopathy. Int J Cardiol 177:429–435CrossRefPubMed Doesch C, Dierks DM, Haghi D et al (2014) Right ventricular dysfunction, late gadolinium enhancement, and female gender predict poor outcome in patients with dilated cardiomyopathy. Int J Cardiol 177:429–435CrossRefPubMed
5.
go back to reference Aebischer N, Meuli R, Jeanrenaud X, Koerfer J, Kappenberger L (1998) An echocardiographic and magnetic resonance imaging comparative study of right ventricular volume determination. Int J Card Imaging 14:271–278CrossRefPubMed Aebischer N, Meuli R, Jeanrenaud X, Koerfer J, Kappenberger L (1998) An echocardiographic and magnetic resonance imaging comparative study of right ventricular volume determination. Int J Card Imaging 14:271–278CrossRefPubMed
6.
go back to reference Rajappan K, Bellenger NG, Anderson L, Pennell DJ (2000) The role of cardiovascular magnetic resonance in heart failure. Eur J Heart Fail 2:241–252CrossRefPubMed Rajappan K, Bellenger NG, Anderson L, Pennell DJ (2000) The role of cardiovascular magnetic resonance in heart failure. Eur J Heart Fail 2:241–252CrossRefPubMed
7.
go back to reference Mooij CF, de Wit CJ, Graham DA, Powell AJ, Geva T (2008) Reproducibility of MRI measurements of right ventricular size and function in patients with normal and dilated ventricles. J Magn Reson Imaging 28:67–73CrossRefPubMedPubMedCentral Mooij CF, de Wit CJ, Graham DA, Powell AJ, Geva T (2008) Reproducibility of MRI measurements of right ventricular size and function in patients with normal and dilated ventricles. J Magn Reson Imaging 28:67–73CrossRefPubMedPubMedCentral
8.
go back to reference Arenja N, Riffel JH, Djiokou CN et al (2016) Right ventricular long axis strain-validation of a novel parameter in non-ischemic dilated cardiomyopathy using standard cardiac magnetic resonance imaging. Eur J Radiol 85:1322–1328CrossRefPubMed Arenja N, Riffel JH, Djiokou CN et al (2016) Right ventricular long axis strain-validation of a novel parameter in non-ischemic dilated cardiomyopathy using standard cardiac magnetic resonance imaging. Eur J Radiol 85:1322–1328CrossRefPubMed
9.
go back to reference Riffel JH, Andre F, Maertens M et al (2015) Fast assessment of long axis strain with standard cardiovascular magnetic resonance: a validation study of a novel parameter with reference values. J Cardiovasc Magn Reson 17:69CrossRefPubMedPubMedCentral Riffel JH, Andre F, Maertens M et al (2015) Fast assessment of long axis strain with standard cardiovascular magnetic resonance: a validation study of a novel parameter with reference values. J Cardiovasc Magn Reson 17:69CrossRefPubMedPubMedCentral
10.
go back to reference Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93:841–842CrossRefPubMed Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93:841–842CrossRefPubMed
11.
12.
go back to reference Johnson RA, Palacios I (1982) Dilated cardiomyopathies of the adult (first of two parts). N Engl J Med 307:1051–1058CrossRefPubMed Johnson RA, Palacios I (1982) Dilated cardiomyopathies of the adult (first of two parts). N Engl J Med 307:1051–1058CrossRefPubMed
13.
go back to reference Michels VV, Driscoll DJ, Miller FA et al (2003) Progression of familial and non-familial dilated cardiomyopathy: long term follow up. Heart 89:757–761CrossRefPubMedPubMedCentral Michels VV, Driscoll DJ, Miller FA et al (2003) Progression of familial and non-familial dilated cardiomyopathy: long term follow up. Heart 89:757–761CrossRefPubMedPubMedCentral
14.
go back to reference Miller WL, Hartman KA, Burritt MF, Burnett JC Jr, Jaffe AS (2007) Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies. Clin Cardiol 30:245–250CrossRefPubMed Miller WL, Hartman KA, Burritt MF, Burnett JC Jr, Jaffe AS (2007) Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies. Clin Cardiol 30:245–250CrossRefPubMed
15.
go back to reference Gulati A, Jabbour A, Ismail TF et al (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309:896–908CrossRefPubMed Gulati A, Jabbour A, Ismail TF et al (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309:896–908CrossRefPubMed
16.
go back to reference Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977–1985CrossRefPubMed Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977–1985CrossRefPubMed
17.
go back to reference Wu KC, Weiss RG, Thiemann DR et al (2008) Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51:2414–2421CrossRefPubMedPubMedCentral Wu KC, Weiss RG, Thiemann DR et al (2008) Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51:2414–2421CrossRefPubMedPubMedCentral
18.
go back to reference Lehrke S, Lossnitzer D, Schob M et al (2011) Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 97:727–732CrossRefPubMed Lehrke S, Lossnitzer D, Schob M et al (2011) Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 97:727–732CrossRefPubMed
19.
go back to reference Gulati A, Ismail TF, Jabbour A et al (2013) The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. Circulation 128:1623–1633CrossRefPubMed Gulati A, Ismail TF, Jabbour A et al (2013) The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. Circulation 128:1623–1633CrossRefPubMed
20.
go back to reference Juilliere Y, Barbier G, Feldmann L, Grentzinger A, Danchin N, Cherrier F (1997) Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. Eur Heart J 18:276–280CrossRefPubMed Juilliere Y, Barbier G, Feldmann L, Grentzinger A, Danchin N, Cherrier F (1997) Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. Eur Heart J 18:276–280CrossRefPubMed
21.
go back to reference Doesch C, Streitner F, Bellm S et al (2013) Epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure due to dilated cardiomyopathy. Obesity (Silver Spring) 21:E253–E261CrossRef Doesch C, Streitner F, Bellm S et al (2013) Epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure due to dilated cardiomyopathy. Obesity (Silver Spring) 21:E253–E261CrossRef
22.
go back to reference Bonnemains L, Mandry D, Marie PY, Micard E, Chen B, Vuissoz PA (2012) Assessment of right ventricle volumes and function by cardiac MRI: quantification of the regional and global interobserver variability. Magn Reson Med 67:1740–1746CrossRefPubMed Bonnemains L, Mandry D, Marie PY, Micard E, Chen B, Vuissoz PA (2012) Assessment of right ventricle volumes and function by cardiac MRI: quantification of the regional and global interobserver variability. Magn Reson Med 67:1740–1746CrossRefPubMed
23.
go back to reference Doesch C, Zompolou C, Streitner F et al (2014) CMR-derived TAPSE measurement: a semi-quantitative method of right ventricular function assessment in patients with hypertrophic cardiomyopathy. Neth Heart J 22:557–564CrossRefPubMedPubMedCentral Doesch C, Zompolou C, Streitner F et al (2014) CMR-derived TAPSE measurement: a semi-quantitative method of right ventricular function assessment in patients with hypertrophic cardiomyopathy. Neth Heart J 22:557–564CrossRefPubMedPubMedCentral
Metadata
Title
The prognostic value of right ventricular long axis strain in non-ischaemic dilated cardiomyopathies using standard cardiac magnetic resonance imaging
Authors
Nisha Arenja
Johannes H. Riffel
Manuel Halder
Charly N. Djiokou
Thomas Fritz
Florian Andre
Fabian aus dem Siepen
Thomas Zelniker
Benjamin Meder
Elham Kayvanpour
Grigorios Korosoglou
Hugo A. Katus
Sebastian J. Buss
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 9/2017
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4729-0

Other articles of this Issue 9/2017

European Radiology 9/2017 Go to the issue